Literature DB >> 9190929

Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes.

V R Sutton1, D L Vaux, J A Trapani.   

Abstract

Two pathways have been implicated in the induction of apoptosis by cytotoxic T cells: the granule exocytosis pathway and a pathway using CD95 (Fas/APO-1). To test whether apoptosis induced by either of these pathways could be blocked by Bcl-2, we exposed bcl-2-transfected cells to CTL derived from normal, perforin-deficient, or CD95 ligand mutant (gld) mice. Although the levels of Bcl-2 expression achieved were able to protect FDC-P1 and Yac-1 transfectants from a variety of apoptotic stimuli, the cells were not protected from cytolysis mediated by CTL from any of these sources, by NK cells, or granules isolated from CTL. However, Bcl-2 expression significantly inhibited apoptosis induced by purified granzyme B and perforin. These results suggest that while Bcl-2 is capable of inhibiting the apoptotic pathway utilized by perforin and granzyme B, other granule components can bypass this block. We conclude that CTL harbor potent killing mechanism(s) in addition to those provided by CD95 ligand or perforin and granzyme B that cannot be overcome by Bcl-2.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190929

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin.

Authors:  K A Browne; E Blink; V R Sutton; C J Froelich; D A Jans; J A Trapani
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis.

Authors:  D Zhang; P J Beresford; A H Greenberg; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

Review 3.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

5.  Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization.

Authors:  Daniella Brasacchio; Amber E Alsop; Tahereh Noori; Mariam Lufti; Sweta Iyer; Kaylene J Simpson; Phillip I Bird; Ruth M Kluck; Ricky W Johnstone; Joseph A Trapani
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

Review 6.  How anti-PD1 treatments are changing the management of melanoma.

Authors:  Peter Hersey; Hojabr Kakavand; James Wilmott; Andre van der Westhuizen; Stuart Gallagher; Kavitha Gowrishankar; Richard Scolyer
Journal:  Melanoma Manag       Date:  2014-12-04

Review 7.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

8.  Cathepsin H is an additional convertase of pro-granzyme B.

Authors:  Michael E D'Angelo; Phillip I Bird; Christoph Peters; Thomas Reinheckel; Joseph A Trapani; Vivien R Sutton
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

9.  Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation.

Authors:  E Sharif-Askari; A Alam; E Rhéaume; P J Beresford; C Scotto; K Sharma; D Lee; W E DeWolf; M E Nuttall; J Lieberman; R P Sékaly
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

10.  A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage.

Authors:  D Brasacchio; T Noori; C House; A J Brennan; K J Simpson; O Susanto; P I Bird; R W Johnstone; J A Trapani
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.